December 9th 2024
The top 5 most-viewed content from this year's American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease (CVD) Prevention included interviews with Robert Kushner, MD, MS, and Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, as well as coverage on multiple areas of cardiovascular medicine.
November 21st 2024
Delve into the current state of prescription digital therapeutics (PDTs) adoption and uncover strategies for increasing payer approval and achieving widespread coverage of PDTs.
Bevey Miner Talks Interoperability in Digital Health Policy
January 29th 2024Bevey Miner, executive vice president of health care strategy and policy, Consensus Cloud Solutions, discusses the historic progression of health information technology and the role interoperability plays in secure exchanging of patient data.
Read More
Analysis Explores Gene Therapy’s Potential to Be Cost-Effective in SCD
January 22nd 2024This new economic valuation of the societal and health care benefits of gene therapy to treat sickle cell disease (SCD) concludes the highly personalized treatment has potential to be cost effective if priced below $2 million.
Read More
VR-Based Pulmonary Rehabilitation More Effective in Patients With COPD, Study Says
January 21st 2024Virtual reality (VR) combined with pulmonary rehabilitation was more effective than pulmonary rehabilitation alone in improving the pulmonary function, exercise capacity, and mental health of patients with chronic obstructive pulmonary disease (COPD).
Read More
CMS has announced new federal rules that require health insurers to streamline requests to cover treatments; nearly 50,000 veterans used the emergency suicide prevention program launched by the Department of Veteran Affairs in 2023; the FDA recently authorized the first artificial intelligence (AI)-powered medical device to help doctors detect the most common forms of skin cancer.
Read More
Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual Visits
This article compares cardiovascular disease risk management in community clinics during the COVID-19 pandemic among patients for whom primary care was delivered mostly in person vs mostly virtually.
Read More
Real-Time CGM Shows Benefits Over Intermittently Scanned CGM in T1D
January 16th 2024In a systematic review and meta-analysis, real-time continuous glucose monitoring (CGM) demonstrated benefits in terms of time in range, hypoglycemia, and hyperglycemia among patients with type 1 diabetes (T1D).
Read More
Bevey Miner, executive vice president of health care strategy and policy, Consensus Cloud Solutions, shares how extraction artificial intelligence is helping train machine learning models to recognize and extract information from documents, providing structured data with confidence scores.
Watch
Pandemic-Related Practice Changes and CVD Risk Management in Community Clinics
Compared with in-person appointments, virtual care appointments were associated with higher completion rates, shorter time to appointment, increased hemoglobin A1c documentation, and decreased blood pressure documentation.
Read More
How Patients Distinguish Between Clinical and Administrative Predictive Models in Health Care
January 10th 2024Patients are less comfortable with predictive models used for health care administration compared with those used in clinical practice, signaling misalignment between patient comfort, policy, and practice.
Read More
What We’re Reading: Doctor Payment Cuts; Menopause Drug; Student Mental Health Support
January 10th 2024Congress is being urged to reverse a cut to physicians’ Medicare payments; Bayer announced encouraging results on Monday of 2 phase 3 trials for its nonhormonal drug candidate meant to treat hot flashes; more students are turning to online mental health support rather than school counselors.
Read More
What We’re Reading: Canadian Drug Imports; Drug-by-Mail Delivery; Hydroxychloroquine-Related Deaths
January 5th 2024The FDA announced it is allowing Florida to import medications in bulk from Canada at far lower prices than those offered in the United States; health insurance companies are revamping their technology to encourage more people to get their medications through the mail; nearly 17,000 patients with COVID-19 may have died after taking hydroxychloroquine during the first pandemic wave.
Read More
The FDA approved the first test to assess opioid addiction risk; Americans are using more cold and allergy medicines to mask any related symptoms to return to work and social gatherings, but may be overtreating themselves in the process; Rite Aid will be banned from using artificial intelligence–powered facial recognition technology for 5 years under a proposed Federal Trade Commission settlement.
Read More